Phenylephrine Unimedic 0,05 mg/ml inj. sol. i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

phenylephrine unimedic 0,05 mg/ml inj. sol. i.v. amp.

unimedic pharma ab - phenylephrine hydrochloride 0,061 mg/ml - eq. phenylephrine 0,05 mg/ml - solution for injection - 0,05 mg/ml - phenylephrine hydrochloride 0.061 mg/ml - phenylephrine

Phenylephrine Unimedic 0,1 mg/ml inj. sol. i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

phenylephrine unimedic 0,1 mg/ml inj. sol. i.v. amp.

unimedic pharma ab - phenylephrine hydrochloride 0,122 mg/ml - eq. phenylephrine 0,1 mg/ml - solution for injection - 0,1 mg/ml - phenylephrine hydrochloride 0.122 mg/ml - phenylephrine

Phenylephrine Unimedic 10 mg/ml inj./inf. sol. (conc.) i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

phenylephrine unimedic 10 mg/ml inj./inf. sol. (conc.) i.v. amp.

unimedic pharma ab - phenylephrine hydrochloride 12,2 mg/ml - eq. phenylephrine 10 mg/ml - concentrate for solution for injection/infusion - 10 mg/ml - phenylephrine hydrochloride 12.2 mg/ml - phenylephrine

Oxybutynin Unimedic 0,5 ml i.vesic. sol. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

oxybutynin unimedic 0,5 ml i.vesic. sol. vial

unimedic pharma ab - oxybutynin hydrochloride 0,5 mg/ml - eq. oxybutynin 0,454 mg/ml - intravesical solution - 0,5 ml - oxybutynin hydrochloride 0.5 mg/ml - oxybutynin

Phenylephrine Unimedic 0,1 mg/ml inj. sol. i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

phenylephrine unimedic 0,1 mg/ml inj. sol. i.v. amp.

unimedic pharma ab - phenylephrine hydrochloride 0,122 mg/ml - eq. phenylephrine 0,1 mg/ml - solution for injection - phenylephrine

Ravicti European Union - English - EMA (European Medicines Agency)

ravicti

immedica pharma ab - glycerol phenylbutyrate - urea cycle disorders, inborn - other alimentary tract and metabolism products, - ravicti is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate-synthase-i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

Phenylephrine Unimedic 0,1 mg/ml Solution for injection Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

phenylephrine unimedic 0,1 mg/ml solution for injection

unimedic pharma - phenylephrine hydrochloride - solution for injection - 0,1 mg/ml - phenylephrine hydrochloride 0.122 mg/ml - phenylephrine